Literature DB >> 6319664

In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat.

C Schmauss, T L Yaksh.   

Abstract

The intrathecal administration of mu (morphine) and delta (D-Ala2-D-Leu5-enkephalin) but not kappa agonists (ethylketocyclazocine, bremazocine and U50488H) or partial agonists (nalbuphine and buprenorphine) produced a dose-dependent inhibition of all cutaneous thermal (hot plate and tail-flick) responses in the rat. In contrast, on visceral chemical tests (writhing), mu and kappa agonists but not delta agonists exerted a powerful suppression of the response. Whereas the ED50 of morphine on the cutaneous thermal tests did not differ from that observed on the visceral chemical test, agents with significant mu and delta activity (metkephamid and beta-endorphin) showed a prominent reduction in activity on the writhing as compared with the hot plate and tail-flick. Systemic naloxone resulted in a dose-dependent antagonism of the effect of all intrathecal agents. Estimation of the pA2 of mu agents indicated no difference on the hot plate/tail-flick and writhing (pA2 approximately 7). Kappa ligands were selectively resistant to antagonism with naloxone pA2 values for those agonists ranging from 5.9 to 6.6. These observations suggest that there are three discriminable populations of receptors in the spinal cord whose activation results in a selective modulation of the response of the animal to noxious stimuli. In addition, the selective effects of the delta agonists on cutaneous thermal and kappa agonists on visceral chemical suggest a differential coding of spinal afferents through which these stimuli are transmitted.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6319664

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  69 in total

1.  On the selectivity of intravenous mu- and kappa-opioids between nociceptive and non-nociceptive reflexes in the spinalized rat.

Authors:  C G Parsons; P M Headley
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

2.  Dynorphin A decreases voltage-dependent calcium conductance of mouse dorsal root ganglion neurones.

Authors:  R L Macdonald; M A Werz
Journal:  J Physiol       Date:  1986-08       Impact factor: 5.182

3.  Estrogens as arbiters of sex-specific and reproductive cycle-dependent opioid analgesic mechanisms.

Authors:  Alan R Gintzler; Emiliya M Storman; Nai-Jiang Liu
Journal:  Vitam Horm       Date:  2019-07-02       Impact factor: 3.421

4.  Analgesic activity of a novel bivalent opioid peptide compared to morphine via different routes of administration.

Authors:  B S Silbert; A W Lipkowski; M S Cepeda; S K Szyfelbein; P F Osgood; D B Carr
Journal:  Agents Actions       Date:  1991-07

5.  Effects of spinally administered bifunctional nociceptin/orphanin FQ peptide receptor/μ-opioid receptor ligands in mouse models of neuropathic and inflammatory pain.

Authors:  Devki D Sukhtankar; Nurulain T Zaveri; Stephen M Husbands; Mei-Chuan Ko
Journal:  J Pharmacol Exp Ther       Date:  2013-05-07       Impact factor: 4.030

6.  Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on kappa-opioid agonists in the mouse writhing assay.

Authors:  J H Broadbear; S S Negus; E R Butelman; B R de Costa; J H Woods
Journal:  Psychopharmacology (Berl)       Date:  1994-07       Impact factor: 4.530

7.  Spinal antinociceptive actions of mu- and kappa-opioids: the importance of stimulus intensity in determining 'selectivity' between reflexes to different modalities of noxious stimulus.

Authors:  C G Parsons; P M Headley
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

8.  Delta-opioid mediated inhibitions of acute and prolonged noxious-evoked responses in rat dorsal horn neurones.

Authors:  A F Sullivan; A H Dickenson; B P Roques
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

Review 9.  The mediodorsal thalamic nucleus and schizophrenia.

Authors:  Raúl Alelú-Paz; José Manuel Giménez-Amaya
Journal:  J Psychiatry Neurosci       Date:  2008-11       Impact factor: 6.186

10.  Modulation of opioid antinociception by CCK at the supraspinal level: evidence of regulatory mechanisms between CCK and enkephalin systems in the control of pain.

Authors:  F Noble; M Derrien; B P Roques
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.